Pharmaceuticals, Biotechnology and Life Sciences
JERUSALEM–(BUSINESS WIRE)–Teva Pharmaceutical Industries Ltd., (NYSE and TASE: TEVA) today announced the launch of a generic version of Ranexa®1 (ranolazine)…
Approval marks the first chemotherapy-free combination regimen for patients who have relapsed or did not respond to previous treatment Approval…
– Confirmation of VALBIOTIS’s capacity to produce VALEDIA® in compliance with North American and European industrial standards. – A key…
LONDON–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/Analytics?src=hash" target="_blank"gt;#Analyticslt;/agt;–A global data analytics and advisory firm, Quantzig, that delivers actionable analytics solutions to resolve complex business…
DUBLIN–(BUSINESS WIRE)–The “Pharmaceutical Label Market Report: Trends, Forecast and Competitive Analysis” report has been added to ResearchAndMarkets.com’s offering. The global…
DANVILLE, Calif.–(BUSINESS WIRE)–BryoLogyx Inc., (www.BryoLogyx.com), a privately-held, pre-clinical company developing a new class of proprietary drugs to enhance the response…
AMSTERDAM–(BUSINESS WIRE)–Synaffix B.V., a Dutch biotechnology company focused on the advancement of its clinical-stage antibody-drug conjugate (ADC) technology for the…
All German sites of the pharmaceutical service provider will be supplied with green electricity moving forward Vetter contributes to climate…
Proceeds to enable the advancement of lead product candidate AL101 in ACC and TNBC REHOVOT, Israel & WILMINGTON, Del.–(BUSINESS WIRE)–Ayala…
WILMINGTON, N.C.–(BUSINESS WIRE)–Pharmaceutical Product Development, LLC (PPD) won multiple honors in the annual PharmaTimes Clinical Researcher of the Year competitions,…